Blockbuster Pathology Deal Sees Japan’s Miraca Holdings Pay $725 Million to Acquire Caris Diagnostics

Deal may be just the first of more clinical laboratory acquisitions in the U.S by Japan’s largest medical lab testing company Pathology and clinical laboratory testing companies continue to go global and last week’s big acquisition in anatomic pathology gave one of Japan’s biggest clinical laboratory companies an important foothold in the United States. Miraca Holdings Inc. (TYO: 4544.T) of Tokyo, Japan, announced that it would acquire the anatomic pathology business of Caris Life Sciences,...

Sonic Healthcare Buys California Clinical Pathology Laboratory Company

This Medical Laboratory Acquisition Positions Sonic in Nation’s Largest Lab Testing Market Sonic Healthcare, Ltd. (ASX: SHL) acquired Physicians Automated Laboratory, Inc., (PAL) of Bakersfield, California, in a transaction that closed December 31, 2010. With this acquisition, Sonic Healthcare gains its first medical laboratory in California—the nation’s largest and most competitive market for clinical laboratory testing services. Physicians Automated Laboratory was founded in 1967. It employs...

Volume of Clinical Pathology Laboratory Specimens Increases at Bio-Reference and Sonic Healthcare

Meanwhile, both Quest Diagnostics and LabCorp report second quarter declines in specimen volume Fewer patients visiting physician offices during second quarter 2010 is considered to be one reason why specimen volume declined at clinical pathology laboratory testing giants Quest Diagnostics Incorporated (NYSE: DGX) and Laboratory Corporation of America (NYSE: LH) during that three-month period. For second quarter, LabCorp reported a 2% decline in specimen volume, along with a 4.2% increase in...

Rumors Link Quest Diagnostics and Sonic Healthcare in Some Type of Deal

Healthscope bids also fuel speculation of a big clinical pathology transaction Last week in Australia, investment insiders shared rumors that Quest Diagnostics Incorporated (NYSE: DGX) was interested in acquiring Sonic Healthcare Ltd. (ASX: SHL). However, press stories discounted the possibility of a deal between these two billion-dollar clinical pathology laboratory behemoths. Neither company has issued a public statement addressing this issue. In assessing the possibility of Quest...
;